Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects
Pharmacology Research & Perspectives · 2024
DOI: 10.1002/prp2.1253 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Ahmet Inal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Erciyes University Faculty of Medicine, Department of Pharmacology and Erciyes University Good Clinical Practice and Research Center, Kayseri, Turkey. Hauptthemen laut MEDLINE: Ethinyl Estradiol, Therapeutic Equivalency, Androstenes, Fasting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This bioequivalence research aims to evaluate the relative bioavailability and pharmacokinetic characteristics of ethinyl estradiol and drospirenone in the test preparation in comparison to the reference preparation during fasting conditions. A liquid chromatography method with tandem mass spectrometry was used to determine the concentrations of drospirenone and ethinyl estradiol in plasma. The pharmacokinetic parameters that were analyzed were the maximum plasma concentration ( C max ), time to achieve C max ( t max ), elimination half life, and area under the concentration time curve of plasma (AUC 0‐ t , AUC 0‐∞ for ethinyl estradiol, and AUC 0‐72h for drospirenone). Both the AUC and C max parameters were determined to be between 80.00% and 125.00% (90% confidence intervals), which is the acceptable range. Based on the study findings, it was concluded that the test formulation, which includes 3 mg of drospirenone and 0.03 mg of ethinyl estradiol, demonstrated bioequivalence when compared to the reference formulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Erciyes University Faculty of Medicine, Department of Pharmacology and Erciyes University Good Clinical Practice and Research Center, Kayseri, Turkey.
- Biofarma İlaç Sanayi ve Ticaret A.Ş, İstanbul, Turkey.
- Analytisches Zentrum Biopharm GmbH, Berlin, Germany.
- Pharmakin Consulting Services UG, Neu-Ulm, Germany.
- Erciyes University Faculty of Medicine, Department of Family Medicine and Erciyes University Good Clinical Practice and Research Center, Kayseri, Turkey.
- Ideal Contract Research Organisation, Ankara, Turkey.
ORCID-Profile: Ahmet Inal, Zafer Sezer, Berna Uluözlü, Melih Oflas, Martin Reinsch, Wolfgang Martin, Mümtaz M Mazicioglu, Selma Alime Koru
Zitieren
APA
Inal, A., Sezer, Z., Uluözlü, B., Oflas, M., Reinsch, M., Martin, W., Mazicioglu, M. M., & Koru, S. A. (2024). Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1253
Vancouver
Inal A, Sezer Z, Uluözlü B, Oflas M, Reinsch M, Martin W, et al. Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1253
BibTeX
@article{Inal2024,
author = {Inal, Ahmet and Sezer, Zafer and Uluözlü, Berna and Oflas, Melih and Reinsch, Martin and Martin, Wolfgang and Mazicioglu, Mümtaz M and Koru, Selma Alime},
title = {Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects},
journal = {Pharmacology Research & Perspectives},
year = {2024},
doi = {10.1002/prp2.1253}
}
EUVIMED